FP405EFFICACY AND SAFETY OF SEVELAMER CARBONATE IN HYPERPHOSPHATEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS AND NON-DIALYSIS: A PROSPECTIVE, OPEN-LABEL, DOSE-TITRATION STUDY IN RUSSIA

Evgeny Shutov; Natalia Tomilina; Galina Volgina; Andrei Dmitriev

doi:10.1093/ndt/gfy104.fp405

FP405EFFICACY AND SAFETY OF SEVELAMER CARBONATE IN HYPERPHOSPHATEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE ON HEMODIALYSIS AND NON-DIALYSIS: A PROSPECTIVE, OPEN-LABEL, DOSE-TITRATION STUDY IN RUSSIA

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfy104.fp405 ◽

2018 ◽

Vol 33 (suppl_1) ◽

pp. i171-i172

Author(s):

Evgeny Shutov ◽

Natalia Tomilina ◽

Galina Volgina ◽

Andrei Dmitriev

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Dose Titration ◽

Open Label ◽

Sevelamer Carbonate ◽

Label Dose ◽

Titration Study

Download Full-text

Comments on ^|^ldquo;Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study^|^rdquo; ^|^mdash;Efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus [Letter to the Editor]

Endocrine Journal ◽

10.1507/endocrj.ej13-0276 ◽

2013 ◽

Vol 60 (9) ◽

pp. 1115-1115

Author(s):

Kyuzi Kamoi

Keyword(s):

Diabetes Insipidus ◽

Central Diabetes Insipidus ◽

Dose Titration ◽

Efficacy And Safety ◽

Open Label ◽

Orally Disintegrating Tablet ◽

Letter To The Editor ◽

Label Dose ◽

Titration Study

Download Full-text

Pan-European, open-label dose titration study of fentanyl buccal tablet in patients with breakthrough cancer pain

European Journal of Pain ◽

10.1002/ejp.577 ◽

2014 ◽

Vol 19 (4) ◽

pp. 528-537 ◽

Cited By ~ 6

Author(s):

U.R. Kleeberg ◽

A. Davies ◽

J. Jarosz ◽

S. Mercadante ◽

P. Poulain ◽

...

Keyword(s):

Cancer Pain ◽

Dose Titration ◽

Open Label ◽

Breakthrough Cancer Pain ◽

Fentanyl Buccal Tablet ◽

Buccal Tablet ◽

Label Dose ◽

Titration Study

Download Full-text

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: An 8-week, multicenter, randomized, open-label, dose-titration study in korean patients with hypercholesterolemia

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.11.002 ◽

2007 ◽

Vol 29 (11) ◽

pp. 2365-2373 ◽

Cited By ~ 34

Author(s):

Sang Hak Lee ◽

Namsik Chung ◽

Jun Kwan ◽

Doo-Il Kim ◽

Won Ho Kim ◽

...

Keyword(s):

Dose Titration ◽

Open Label ◽

Korean Patients ◽

Label Dose ◽

Titration Study

Download Full-text

An Open-Label Dose-Titration Study of the Efficacy and Tolerability of Tizanidine Hydrochloride Tablets in the Prophylaxis of Chronic Daily Headache

Headache The Journal of Head and Face Pain ◽

10.1046/j.1526-4610.2001.111006357.x ◽

2001 ◽

Vol 41 (4) ◽

pp. 357-368 ◽

Cited By ~ 29

Author(s):

Joel R. Saper ◽

Paul K. Winner ◽

Alvin E. Lake

Keyword(s):

Chronic Daily Headache ◽

Dose Titration ◽

Open Label ◽

Label Dose ◽

Daily Headache ◽

Titration Study

Download Full-text

55: A Randomized, Parallel, Open-Label Study to Compare Sevelamer Carbonate Powder Dosed Once Per Day With Sevelamer Hydrochloride Tablets Dosed Three Times Per Day in Chronic Kidney Disease Patients on Hemodialysis

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2009.01.076 ◽

2009 ◽

Vol 53 (4) ◽

pp. B36

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Sevelamer Hydrochloride ◽

Sevelamer Carbonate

Download Full-text

Efficacy and Safety of Oxybutynin Transdermal System in Spinal Cord Injury Patients With Neurogenic Detrusor Overactivity and Incontinence: An Open-label, Dose-titration Study

Urology ◽

10.1016/j.urology.2009.05.008 ◽

2009 ◽

Vol 74 (4) ◽

pp. 741-745 ◽

Cited By ~ 23

Author(s):

Michael J. Kennelly ◽

Gary E. Lemack ◽

Jenelle E. Foote ◽

Cynthia S. Trop

Keyword(s):

Spinal Cord ◽

Spinal Cord Injury ◽

Detrusor Overactivity ◽

Dose Titration ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Open Label ◽

Cord Injury ◽

Label Dose ◽

Titration Study

Download Full-text

Dose–Response Characteristics in Adolescents with Attention-Deficit/Hyperactivity Disorder Treated with OROS® Methylphenidate in a 4-Week, Open-Label, Dose-Titration Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2009.0102 ◽

2010 ◽

Vol 20 (3) ◽

pp. 187-196 ◽

Cited By ~ 19

Author(s):

Jeffrey H. Newcorn ◽

Mark A. Stein ◽

Kimberly M. Cooper

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Dose Response ◽

Attention Deficit ◽

Dose Titration ◽

Open Label ◽

Response Characteristics ◽

Hyperactivity Disorder ◽

Label Dose ◽

Titration Study

Download Full-text

Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride

Nephrology ◽

10.1111/j.1440-1797.2011.01509.x ◽

2011 ◽

Vol 16 (8) ◽

pp. 743-750 ◽

Cited By ~ 19

Author(s):

JIN-BOR CHEN ◽

SHOU-SHAN CHIANG ◽

HUNG-CHUN CHEN ◽

SEIICHI OBAYASHI ◽

MASAKI NAGASAWA ◽

...

Keyword(s):

Phosphate Binder ◽

Dose Titration ◽

Efficacy And Safety ◽

Open Label ◽

Free Iron ◽

Asian Patients ◽

Sevelamer Hydrochloride ◽

Label Dose ◽

Titration Study

Download Full-text

Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study

Endocrine Journal ◽

10.1507/endocrj.ej13-0165 ◽

2013 ◽

Vol 60 (9) ◽

pp. 1085-1094 ◽

Cited By ~ 21

Author(s):

Hiroshi Arima ◽

Yutaka Oiso ◽

Kristian Vinter Juul ◽

Jens Peter N^|^oslash;rgaard

Keyword(s):

Diabetes Insipidus ◽

Central Diabetes Insipidus ◽

Dose Titration ◽

Efficacy And Safety ◽

Open Label ◽

Orally Disintegrating Tablet ◽

Label Dose ◽

Titration Study

Download Full-text

Faculty Opinions recommendation of Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.733467482.793553182 ◽

2018 ◽

Author(s):

Vlado Perkovic ◽

Brendan Smyth

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Insulin Glargine ◽

Randomised Trial ◽

Open Label ◽

Severe Chronic Kidney Disease

Download Full-text